Next Article in Journal
Anti-Mullerian Hormone-Based Phenotyping Identifies Subgroups of Women with Polycystic Ovary Syndrome with Differing Clinical and Biochemical Characteristics
Previous Article in Journal
Prevalence of Second Root and Root Canal in Mandibular and Maxillary Premolars Based on Two Classification Systems in Sub-Population of Northern Region (Saudi Arabia) Assessed Using Cone Beam Computed Tomography (CBCT): A Retrospective Study
 
 
Interesting Images
Peer-Review Record

Partially Dedifferentiated Primitive Malignant Melanoma with Pseudo-Angiomatous Features: A Case Report with Review of the Literature

Diagnostics 2023, 13(3), 495; https://doi.org/10.3390/diagnostics13030495
by Francesca Ambrogio 1, Anna Colagrande 2, Eliano Cascardi 3,4, Mauro Grandolfo 1, Raffaele Filotico 1, Caterina Foti 1, Carmelo Lupo 5, Nadia Casatta 5, Giuseppe Ingravallo 2,* and Gerardo Cazzato 2,*
Reviewer 1:
Reviewer 2:
Diagnostics 2023, 13(3), 495; https://doi.org/10.3390/diagnostics13030495
Submission received: 25 December 2022 / Revised: 19 January 2023 / Accepted: 20 January 2023 / Published: 29 January 2023
(This article belongs to the Section Pathology and Molecular Diagnostics)

Round 1

Reviewer 1 Report

The authors described "Partially dedifferentiated primitive Malignant Melanoma with pseudo-angiomatous features: a case report with review of the literature". As they mentioned, this case should be rare and informative for potential readers. However, I have some concerns about the content as follows.

1. This manuscript is "Case Report". So, they must describe the case in more detail (e.g. How about postoperative course? How about therapy for this case?). Please add it.

2. Please separate case and discussion from main text.

3. How about LYVE1 immnunostaining? Can Malignant Melanoma with pseudo-angiomatous features metastasis through lymphatic vessels?

Author Response

Reviewer n’1: This manuscript is "Case Report". So, they must describe the case in more detail (e.g. How about postoperative course? How about therapy for this case?). Please add it.

Answer n’1: Dear Reviewer n’1, thank you very much for these useful tips to improve the quality of our manuscript. We, currently, add some informations about our patient. Thanks again.

Reviewer n’1: Please separate case and discussion from main text.

Answer n’2: thank you very much, actually we separated it even though as a format of "interesting image" from Diagnostics it should be kept together.

Reviewer n’1: How about LYVE1 immnunostaining? Can Malignant Melanoma with pseudo-angiomatous features metastasis through lymphatic vessels?

Answer n’3: Thank you very much, actually we performed it as an immunohistochemical marker but it turned out to be negative, as this type of MM has no progression characteristics other than common melanoma histotypes, with no particular tropism for lymphatic vessels. Thank you for everything.

Reviewer 2 Report

Delate Figure on Table 4-it is redundant with text and not necessary. 

Comment: as a non-Pathologist this does not sounds like a very challenging case-the differentiated components were strongly positive for all melanoma markers.  

Author Response

Dear Reviewer n'2, thank you very much. We removed the table of the figure 4.

A warm greeting

Round 2

Reviewer 1 Report

The authors revised the article precisely.

Back to TopTop